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ABSTRACT 
The cytoplasmic inheritance of human chloramphenicol (CAP) resistance has been 
demonstrated  by removing the  nuclei  of cells of the  CAP-resistant  HeLa strain 
296-1  (enucleation)  and  fusing  them  to  a  CAP-sensitive  HeLa  strain  lacking 
nuclear thymidine kinase.  Plating  the  fusion  products in bromodeoxyuridine and 
CAP  resulted  in  the  growth  of  about  150  colonies/106  parent  cells  plated. 
Permanent cell lines (cybrids) grown from such fusions have been designated HEB. 
A  recloned  HEB  cybrid  (HEB7A)  has  also  been  enucleated  and  fused  to 
hypoxanthine  phosphoribosyl transferase (HPRT)-deficient  HeLa cells (S3AGI) 
and  HPRT-deficient  lymphocytes (WAL-2A).  Cybrids were  selected  in  thiogua- 
nine  and  CAP.  In  the  fusion  of  enucleated  (en)  HEB7A  to  S3AGI,  1,200 
colonies/106 parents were observed. Fusion of enHEB7A to WAL-2A was done in 
mass culture and cybrids were obtained on three separate occasions. In every case 
the parental controls were negative. 
All isolates tested from the above fusions have the CAP-resistant characteristics, 
in vivo and in vitro, of the enucleated parent and the nuclear characteristics of the 
CAP-sensitive  parent,  such  as  chromosome  number,  morphology,  and  specific 
isozyme  and  chromosome  markers.  Therefore,  it  can  be  concluded  that  CAP 
resistance  is  coded  in  the  cytoplasm  and  not  in  the  nucleus  of  296-1  cells. 
Furthermore,  this resistance can be transferred to cells of widely different origin 
and  differentiated  state.  These  studies  represent  the  first  genetic  evidence  of 
cytoplasmic inheritance  in human cells. 
Human  mitochondria  from  HeLa  cells  contain 
closed circular DNA molecules approximately 4.8 
,m in length or about 9.4  ￿  106 daltons (d) mo- 
lecular weight (34). These genomes carry one gene 
for each rRNA (1.7-2.1  ￿  106 d of DNA) and  12 
4S RNAs (0.6  x  106 d) (I, 2, 45).  About  14 pro- 
teins of 3.0 x  10' d could be coded in the remain- 
ing 6.9  ￿  106 d of mitochondrial DNA (mtDNA). 
A  genetic  investigation  of the  specific  coding 
functions  of  mtDNA  requires  the  isolation  of 
mitochondrial  mutants.  Previously,  this  labora- 
tory  described  a  stable  mutant  HeLa  cell  line, 
296-1,  whose  growth  and  mitochondrial  protein 
synthesis  in  vitro  is  resistant  to  levels  of chlor- 
amphenicol (CAP) which eliminate mitochondrial 
protein  synthesis  of the  sensitive  parent (18,  39). 
Mitochondrial protein synthesis  of this mutant in 
vitro is unaffected by CAP even in the presence of 
0.01% Triton X- 100, suggesting  that the resistance 
does  not  result  from  mitochondrial  membrane 
permeability. The  question  remains whether  the 
mutation  arose  in  the  mtDNA  and,  therefore, 
would  be cytoplasmically inherited. 
A  mitochondrially  coded  erythromycin-re- 
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lated  with  an  altered  pattern  of  mitochondrial 
ribosomal  proteins  (5,  42).  Mitochondrial coding 
of  mutations  to  antibiotic  resistance  in  Para- 
mecium  has  been  demonstrated  by  injecting  iso- 
lated  mitochondria from  resistant cells into sensi- 
tive  ones.  Generation  of  resistant  cells  suggests 
that the gene is carried  with the mitochondria (4, 
5, 22). CAP resistance has been shown to be mito- 
chondrially  coded  in  Paramecium  (4)  and  in 
yeast  (9),  and  cytoplasmically  inherited  in 
Tetrahymena  (35). 
In  our  previous  paper  we  described  a  method 
to demonstrate that CAP resistance in mouse cells 
was  cytoplasmically  coded  (7).  The  nuclei  of 
CAP-resistant cells were  removed  and the result- 
ing  cytoplasmic  fragments  were  fused  to  CAP- 
sensitive  cells.  Development  of  a  CAP-resistant 
line  indicated  that  the  determinant  of  CAP  re- 
sistance  was  carried  in  the  cytoplasm.  In  this 
paper we have used such a  system to demonstrate 
the  first  genetic  evidence  of  cytoplasmic  inheri- 
tance  in  human  cells.  A  preliminary  report  of 
these results has been presented elsewhere (43). 
MATERIALS  AND  METHODS 
Cell Lines 
The human HeLa cell clone, $3 (14,  32),  was used in 
this study. The isolation and growth characteristics of a 
CAP-resistant  $3  line,  designated  296-1,  have  been 
described (39). 
The  HeLa cell line BU25 was also derived from $3 
(19). This line is resistant to high levels of bromodeoxy- 
uridine (BrdU) and possesses only 2-5% of the wild-type 
thymidine kinasr  (TK). 
Three other drug-resistant lines have been isolated for 
this study. These all lack the salvage enzyme hypoxan- 
thine phosphoribosyl transferase (HPRT). 
S3AG1 was isolated after treatment of 4 ￿  l06 $3 cells 
with  l  ￿  l0  -6  M  ICR-372 (an acridine mustard muta- 
gen, the gift of Dr. Creech, see reference 10) for 72 h. The 
cells were washed three times with saline and grown an 
additional 72 h in nonselective medium. They were then 
challenged with 3 tzg/ml 8-azaguanine (AG) and after 20 
days the surviving cells were transferred into  12 ~g/ml 
AG. The cells were maintained at this level until colonies 
developed.  These  cells  were  then  challenged  with  80 
jzg/ml AG and allowed to grow for 20 days. The culture 
was then cloned in medium containing 0.12% agar and 80 
~g/ml  AG.  A  single clone was  picked and designated 
S3AGI. S3AGI grows at the same rate in 80/~g/ml AG 
and  in  4  ￿  10-'  M  6-thioguanine (TG) as  it does  in 
nonselective media.  It  is  killed  in  medium  containing 
hypoxanthine, aminopterin, and  thymidine (HAT) (26, 
41) and contains no detectable H PRT activity (Table I). 
Line  300-4b  was  derived  from  296-1  and  is  CAP 
resistant. Approximately 5 ￿  l05 cells were treated with 
5  ￿  10  -e  M  ICR-372  for  24  h.  Survivors were  then 
washed  three  times  in  saline  and  allowed  to  grow  in 
nonselective  medium  for  16  days.  They  were  then 
challenged  with  3  #g/ml  AG,  and  the  survivors were 
transferred into medium  containing 6  #g/ml  AG.  The 
resulting culture was then cloned twice in 6 ~g/ml AG, 
first in petri dishes and then in 0.12% agar. 
One of the resulting clones was grown in 2 ￿  10 -~ M 
1CR-372  for 24 h and washed three times. The cells were 
challenged  immediately  with  12  /~g/ml  AG  and  the 
survivors were allowed to grow for  17 days.  5  ￿  106 of 
these  cells  were  then  challenged  with  60  ttg/ml  AG. 
These  cells  were  unaffected  by  this level  and  so  were 
cloned  in  petri  dishes.  A  single  clone  was  designated 
300-4b. The line grows indefinitely in 60/~g/ml AG and 
in  1 ￿  10  -4  M  TG.  No detectable HPRT activity was 
observed in 300-4b (Table [). 
Strain  300-4b  is  HAT  sensitive,  although  a  low 
reversion rate of about 0.002%  is observed after treat- 
ment with inactive Sendai virus and incubation for over 
20 days.  A  similar observation on HAT  reversion rate 
has been made for the line D98/AH (41). This line was 
obtained from Detroit-98, a presumptive HeLa line (13), 
by stepwise selection of resistance to AG and azahypox- 
anthine.  In  HAT,  0.1%  of  the  D98/AH  cells  were 
observed to revert to resistance. 
WAL-2A  is  an  HPRT-negative  derivative  of  the 
human diploid lymphocyte line WI-L2 (24).  The latter 
strain was grown in suspension for 24 h in 2.5  ￿  10  -6 M 
ICR-372. After growth in the absence of selective agent 
TABLE  I 
HPRT Activity of Parents and Their AG- and 
TG-Resistant  Mutants 
Strain*  HPRT* 
sp act 
S 3  160 
S3AGI  0 
296-1  230 
300-4b  0 
WI-L2A  180 
WAL-2A  0 
* In each  pair of strains the parent is listed above the 
AG- and TG- resistant mutant. WI-L2 was recioned be- 
fore selection of WAL-2A, yielding line WI-L2A. 
Specific  activity  units  are  nanomoles  hypoxanthine 
converted  to  IMP  per  hour  per  milligram  protein  at 
240C.  Zero  indicates no detectable activity--less than 
0.02 nmol/h/mg protein. 
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AG. Cells which grew in AG were then cloned in 0.12% 
agar once in 3 #g/ml AG, once in 5 #g/ml AG, and once 
in  1  ￿  10 -6  M  TG.  The  resulting  strain,  designated 
WAL-2A, grows in  1 x  10 -4 M  TG,  is HAT sensitive, 
and shows no HPRT activity (Table i). WI-L2 contains a 
Y  chromosome  and  the  glucose-6-phosphate dehydro- 
genase  (G6PD)  variant  B,  while  HeLa  lacks  a  Y 
chromosome and is G6PD  variant A  (13,  30,  31, Table 
Vll). 
Enucleation 
The  method  of  enucleation  used  in  this  study  is 
designed to  obtain  large  numbers  of enucleated  fibro- 
blasts (11). All enucleations were performed in MEM-E 
+  10%  fetal calf serum  +  50 ~tg/ml CAP.  In the first 
fusion between enucleated (en) 296-1  and BU25 cells, the 
method was modified by preincubation of the attached 
cells in medium containing 20 #g/ml cytochalasin B for 3 
h  at  37~  followed  by  centrifugation  in  20  #g/ml 
cytochalasin  B in an SW27  rotor at  10,000  rpm for 45 
min.  This  treatment  was  followed  by  a  3-h  recovery 
period in the absence of cytochalasin B. In all subsequent 
enucleations, the method was modified by preincubation 
for 2 h at  10 #g/ml cytochalasin B, followed by a 45-min 
centrifugation at  15,000  rpm in an SW 27  rotor in the 
presence  of  2  #.g/ml  cytochalasin  B.  Recovery  was 
allowed for  1 h  in  the  absence of cytochalasin  B.  The 
resulting enucleated fragments, cytoplasts (36), were then 
removed  from  the  tubes  with  Viokase  (Grand  Island 
Biological Co., Grand Island, N.Y.) and washed once in 
saline before fusion. The percentage of cytoplasts relative 
to  nuclei  and  whole cells  was  determined by  counting 
cells stained with lactopropionic orcein (12). 
Cell Fusion 
Between 3 and 5  ￿  106 cells of each parent were fused 
at a  1:1  ratio with  1,000  hemagglutination units (HAU) 
of inactive Sendai virus, as previously described (7).  All 
parental  controls of enucleation experiments were also 
virus  treated  at  approximately  the  same  virus-to-cell 
ratio  to  check  for  virus-induced  mutation.  Fusions  in 
which  WAL-2A  cells  were  used  employed  a  modified 
lymphocyte  trypsin  pretreatment  (40).  WAL-2A  cells 
were washed once in saline and then incubated for 6 min 
at  37~  in  0.001%  trypsin  in  saline.  The  trypsin  was 
inactivated  by  adding  1.5  vol  of  medium  containing 
serum,  and  then  the  cells  were  washed  once  again  in 
saline.  All  other  cell  lines  were  grown  in  monolayers. 
Before fusion, the line was harvested with Viokase and 
washed once in saline. 
Media 
The  medium  used  for  fibroblastic  cell  fusions  was 
MEM-E supplemented with  10%  fetal calf serum,  100 
U/ml of penicillin, and 100 ~tg/ml streptomycin. The one 
exception was in the fusion of 300-4b and BU25, selected 
in HAT +  CAP, where 5% fetal calf serum plus 5% calf 
serum was used. In fusions involving the lymphocyte line 
WAL-2A, RPMI  1640, containing 592 mg/L-glutamine 
and  supplemented with  15%  heat-inactivated  fetal calf 
serum plus penicillin and streptomycin, was employed. 
Cloning 
Two methods of cloning cells were used in this study. 
The semisolid agar method involved suspending the cells 
in 0.12% Noble agar (Difco, Detroit, Mich.) prepared in 
growth  medium  containing  serum.  Clones  were  also 
picked from petri dishes and flask surfaces with stainless 
steel cloning rings (33). 
Karyotyping 
Late  exponential  phase  cells were  arrested  with  0.1 
t~g/ml  colchicine  and  swollen  in  hypotonic  buffer  for 
10-15  min.  The  cells  were  then  fixed  with  methanol- 
acetic acid (3:1) and spread on slides. 
Chromosomes were counted after staining with lactic- 
acetic orcein (44).  To identify the Y  chromosome, cells 
were  stained  by  a  modification of the Q  band  method 
(30).  Slides  were  stained  for  15  min  in  0.5%  Atebrin 
(Bio/Medical  Specialties,  Santa  Monica,  Calif.),  and 
then rinsed for 3 min in running distilled water. The slides 
were then  drained  and  mounted  in Tris-maleate buffer 
(pH  5.6),  and the cover slip was sealed with nail polish. 
The  slides  were  examined  with  a  Zeiss  transmission 
fluorescence  microscope  fitted  with  a  dark-field  con- 
denser and illuminated with an HBO 200 mercury vapor 
lamp. The excitation filter BGI2, with or without BG38, 
was used with barrier filters 50 or 47. 
Enzyme Assays 
HPRT  activity  was  measured  in  whole cell extracts 
(25) after the transfer of the phosphorylated ribose group 
from  5-phosphoribosyl-l-pyrophosphate to  radioactive 
hypoxanthine (15).  TK activity was assayed by examin- 
ing the phosphorylation of labeled thymidine from ATP. 
Standard assay conditions were used except that 3-phos- 
phoglycerate  was  omitted  from  the  reaction  (21,  27). 
Preparation of TK cell extracts was modified by reducing 
the thymidine level to 60 #g/ml in all solutions (27). Cell 
debris  from  homogenized cells  in  the  TK  extract  was 
removed by a 40-min centrifugation at 35,000 g. inosinic 
acid  and  thymidylic  acid  were  separated  from  their 
labeled precursors by differentially binding the phospho- 
rylated compounds to DEAE paper (6). 
G6PD  isozyme variants A  and  B  were separated by 
cellulose acetate strip electrophoresis (38).  Enzyme ex- 
tracts  were prepared  from  cells washed twice in 0.85% 
saline,  homogenized in  distilled water, and  clarified by 
centrifugation for 60 min at 35,000 g. The Folin method 
was used for all protein determinations (28). 
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Cells were grown in the absence of CAP in glass roller 
bottles  and  harvested  with  Viokase.  The  mitochondria 
were  purified  by  differential  centrifugation  and  the 
isolated  mitochondria  were  tested  for  their  ability  to 
incorporate [SH]leucine into hot TCA-insoluble material 
in  vitro.  The  experimental  details  for  mitochondrial 
purification  and  protein  synthesis  in  vitro  have  been 
previously described  (39).  The  specific  activity  of the 
L-[4,5-SH]leucine  (New  England  Nuclear,  Boston, 
Mass.) was 40.7  Ci/mmol and the scintillation counter 
efficiency was about 30%. 
Growth and Sensitivity Curves 
To determine the sensitivity  of cells to BrdU and TG, 
cells were grown in 30/zg/ml BrdU or 1 ￿  10 -4 M TG 
until  growth  ceased.  HeLa  cells are  sensitive  to  both 
drugs  and  continuous  growth  stops  within  4  days. 
WAL-2A and  its derivatives are sensitive  to BrdU, but 
will grow for 5-7 days  in  50 ml of stationary medium 
before growth ceases.  Growth  rates in various selective 
media  and  sensitivity  to  various  levels  of CAP  were 
determined as previously described (39). 
RESULTS 
Experimental Design 
A  schematic representation  of the method used 
for  demonstrating  cytoplasmic  inheritance  is 
shown  in  Fig.  1.  HeLa cells which are resistant to 
CAP  and  sensitive  to  BrdU  (TK  present)  are 
enucleated.  The resulting cytoplasts  are harvested 
and fused to human  CAP-sensitive cells which are 
CAP R  HeLa CELLS 
(BrdU or TG sensitive) 
1 
ENUCLEATE 
(cytochalasin B + centrifugation) 
,/ 
(nuclei)  (cytoplasm + mitochondria) 
resistant  to  BrdU.  The  fusion  mixture  is  then 
inoculated  into  medium  containing  BrdU  and 
CAP. 
CAP kills the CAP-sensitive parents  and  BrdU 
kills any CAP-resistant parents that have escaped 
enucleation.  The  BrdU  also  kills  any  nuclear- 
nuclear fusion product involving a nucleated CAP- 
resistant  cell, since the TK gene will be expressed 
and confer sensitivity to  BrdU on the hybrid cell. 
The  only cells that  can grow, therefore,  are the 
products  of  a  fusion  between  a  CAP-resistant 
cytoplast  and  a  BrdU-resistant  cell.  Such  cells 
which  grow  into  continuous  cell  lines  have  been 
previously  designated  cytoplasmic  hybrids  or  cy- 
brids (7).  Similar experiments can  be done by use 
of HPRT  as  the  nuclear  marker  and  TG  as  the 
selective agent. 
Demonstration of Cytoplasmic  Inheritance 
of CAP Resistance in 296-1 
To demonstrate cytoplasmic inheritance of CAP 
resistance,  296-1  cells  were  enucleated  (en296-1) 
and  fused to  BU25  which  lacks  TK and  is CAP- 
sensitive.  Selection  was  carried  out  in  25  ~tg/ml 
BrdU  and  50 #g/ml CAP.  As shown in Table  II, 
colonies arose in about  18 days in flasks containing 
the  fusion  mixture,  while  no  colonies  developed 
when the parents were plated alone. The number of 
colonies appearing in each flask follows a dilution 
sequence and the frequency of colony formation is 
about  150  cybrids/10 e  total  parents  plated.  Cy- 
brids  from these fusions are designated  HEB. 
CApsHUMAN CELLS 
x~  (BrdU or TG resistant) 
FUSE WITH 
SENDAl VIRUS 
1 
SELECT 
with CAP and drug to which 
CApSparent is resistant 
1 
CLON ES 
"cytoplasmic hybrid = cybrid" 
(nucleus of CAps parent + cytoplasm of CAP" parent) 
FIG.  1  Procedure used  for construction of human  cybrids.  Superscript R  indicates that the cell line  is 
resistant; an S  indicates that it is sensitive. 
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Fusion  of en296-1  and  BU25* 
Mean no. colonies 
Cells plated  No. cells  per flask  No. flasks  per flask  Clones per l0  s cells 
en296-1~  1 ￿  10  e  2  TNTCw  -- 
￿  5 ￿  105  4  63  126 
BU25  2.5  ￿  105  4  35  140 
1  ￿  l0 s  4  18  180 
BU25  2.6  ￿  10ill  --  0  0 
en296-1  8 ￿  10511  --  0  0 
* Cybrids were formed by the fusion of the parental cells, enucleated (en) 296-1 and BU25. The medium contained the 
inhibitors 25 pg/ml BrdU and 50 ug/ml CAP to select for the cybrids. Cells were plated at different cell densities  and 
colonies were counted after 18 days. 
52% of the 296-1 cells used in this experiment were cytoplasts. 
w  TNTC means too numerous to count. 
II These numbers represent the total number of cells plated in all flasks. 
Fig.  2  shows  the effects of the  selective system 
on  growth  of  the  parental  lines  and  a  recloned 
cybrid, HEB7A, from this experiment. The growth 
of strain  296-1  is unaffected by 50 pg/ml of CAP 
in  the  medium.  When  it  is  grown  in  30  pg/ml 
BrdU  plus  50  pg/ml  CAP,  however,  the  culture 
undergoes  about  one  cell  division  when  growth 
ceases.  BU25,  in  the  presence  of 30 pg/ml  BrdU 
and  50 pg/ml CAP, grows exponentially until the 
delayed effect of CAP is expressed,  at which time 
the  culture  dies.  In  contrast,  the  growth  of  the 
cybrid,  HEB7A, is unaffected by the combination 
of 30 pg/ml BrdU  and  50 pg/ml CAP. Thus,  the 
cybrid exhibits the nuclear characteristics of BU25 
and the CAP resistance of 296-1. 
A  summary  of all experiments  on the cytoplas- 
mic inheritance  of 296-1  CAP resistance is shown 
in  Table  III.  The  first  line  describes  the  above 
experiment. The second is a  repeat of that experi- 
ment using 30 pg/ml BrdU and 50 pg/ml CAP. In 
both  instances,  colonies  arose  at  a  frequency  of 
150/106  parental  cells  plated.  Fusion  of  296-1 
without previous enucleation to BU25 followed by 
selection  in  30  pg/ml  BrdU  and  50 pg/ml  CAP 
resulted  in a  very low frequency of colony forma- 
tion, about 2.2/106 parents plated. This result rules 
out  the  possibility  that  cybrid  formation  is  the 
result of a  nuclear-nuclear  fusion followed by loss 
of the 296-1  chromosomes coding for TK. The few 
colonies that do appear  could be explained by the 
loss of 296-1  chromosomes resulting from prema- 
ture chromosome condensation after fusion of cells 
in  different  stages  of  the  cell  cycle.  It  has  been 
observed that when HeLa cells in G 1 or S phase are 
fused with cells in late G~ or M, the chromosomes 
of the  younger  cells condense without completely 
replicating (16).  G1 or S  phase  296-1  fused with a 
late G2 or M  phase BU25 could result in loss of the 
296-1  chromosomes  coding  for  TK  and  might 
explain the appearance  of the colonies observed. 
The fourth line in Table I11 shows that when the 
age-~  IcAe  ,.~o)  i./e 
|07  B~//HEBTA  (BrdU 30"1"  CApSO) 
J/ 
~~  =~/Ia  " 
Z96-1 (8rdU sO + CAP  50) 
SO  5 
e*,-e BU25 ( BrdU  30 + CAp  50) 
10  4  I  I 
0  IO0  ZOO  3OO 
TIME  IN  HOURS 
FIG.  2  Growth curves in selective agents of parents and 
a cybrid from the fusion en296-1  ￿  BU25. Filled squares 
(11) represent the parent 296-1 grown in medium contain- 
ing  50 vg/ml CAP.  Open  circles (O)  represent  296-1 
grown  in  30  pg/ml  BrdU  and  50 pg/ml  CAP.  Filled 
circles  (0)  represent  growth  of  the  parent  BU25  in 
medium containing 30 vg/ml BrdU and 50 pg/ml CAP, 
and  the  open  squares  (r-i) represent  the growth  of the 
cybrid HEB7A in 30 pg/ml BrdU and 50 ug/ml CAP. 
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fused  to  BU25  and  selection takes  place in  HAT 
plus  50  #g/ml  CAP,  colonies  appear  at  a  rate 
slightly  greater  than  one-third  that  of  cybrid 
formation. Cultures resulting from this fusion have 
been designated  HAB. 
Plating the virus-treated parental cell lines alone 
results  in  no  colonies  which  grow  in  BrdU  and 
CAP.  Similarly,  300-4b  or  BU25  do  not  form 
colonies in the presence of HAT plus CAP in the 
time indicated. 
Table IV gives the nuclear characteristics of the 
parents  and  representative  hybrids  and  cybrids 
from  the  previous  fusions.  It  is  clear  that  the 
chromosome  numbers  of  the  HAB  hybrids  are 
about  120,  which  is  close  to  the  sum  of  the 
chromosome  numbers  of the  two  parents,  BU25 
and  300-4b.  On  the  other  hand,  the chromosome 
numbers of the HEB cybrids are equivalent to that 
of BU25,  less than  that  of 296-1,  and  not  nearly 
that  found  in  the hybrids.  Thus,  the  HEB clones 
are not the product  of a  nuclear-nuclear  fusion. 
Morphology was distinctive here. The 296-1  cell 
is  rounded  and  highly  refractile  while  the  BU25 
cell is large, flattened, and gray. All of the cybrids 
had the flat morphology of BU25. Thus, the HEB 
cybrids  have  the  nuclear  characteristics  of BU25 
and  not 296-1. 
The effects of increasing concentrations of CAP 
on the growth of the parents 296-1  and  BU25 and 
the cybrid HEB7A are shown in Fig. 3. The 296-1 
line is  resistant  to  levels of CAP  that  completely 
inhibit  BU25.  HEB7A  shows  resistance  to  CAP 
similar  to  296-1.  Comparable  results  have  been 
obtained  for  two  other  cybrids,  HEB3A  and 
HEB4A.  Thus,  cybrid  formation  generates  a  cell 
that  has  the  same  CAP  resistance  as  the  CAP- 
resistant donor. 
The  ability  of isolated  mitochondria  of 296-1, 
BU25, and  HEB7A to incorporate labeled leucine 
into mitochondrial protein  was examined in vitro. 
The  effects  of  CAP  and  cycloheximide  (CHX) 
were  then  tested  (Table  V).  CAP-resistant  mito- 
chondrial protein synthesis was found for both the 
CAP-resistant  parent,  296-1,  and  the  cybrid, 
HEB7A. Mitochondrial protein synthesis of BU25 
was found to be CAP sensitive. Protein synthesis in 
all  three  types  of mitochondria  was  found  to  be 
resistant  to  CHX,  proving  that  the  differences 
cannot  be  explained  by  contaminating  cytosol 
ribosomes.  These experiments  in  vitro prove that 
the  resistance  transferred  with  the  cytoplast  still 
resides  in  the  mitochondria.  This  rules  out  the 
possibility  that  CAP  resistance  is  the  result  of 
some secondary  change  occurring  in the recipient 
cell during cybrid formation. 
These  data,  in  conjunction  with  the  absence  of 
colonies formed when the CAP-sensitive parent is 
plated  alone,  the high  frequency  of generation  of 
CAP-resistant  colonies  during  cybrid  formation, 
TABLE III 
Summary Of Fusions Related to Cybrid Formation in the en296-t  ￿  BU25 System 
Total cells  Selective  Colonies/  Time of  Culture 
Cells  Enuclcatioo*  fused:l:  mediumw  IO  ~  r162  count ￿82  dsignation 
%  days 
en296-1  ￿  BU25  52  6 ￿  10  ~  BrdU + CAP  150  18  HEB 
;n296-1  ￿  BU25  34  ! x  107  BrdU + CAP  150  25  HEB 
296-1 x  BU25  0  I ￿  l0  T  BrdU + CAP  2.2  26  -- 
300-4b ￿  BU25  0  1 x  l0  T  HAT + CAP  59  13  HAB 
en296-1  52  1 x  106  BrdU + CAP  0  18  -- 
en296-1  34  3 ￿  106  BrdU + CAP  0  25  -- 
BU25  0  3 ￿  10  ~  BrdU + CAP  0  18  -- 
BU25  0  3 ￿  10  a  BrdU + CAP  0  25  -- 
300-4b  0  5 ￿  10  ~  HAT + CAP  0  13  -- 
BU25  0  5 x  iO  s  HAT + CAP  0  13  -- 
* The percentage of the total parental cells plus fragments which were cytoplasts. 
~/In all cases, where two cell types were employed, the ratio of parents was  1:1. Thus, the number of cells of each 
parent was 50% of the number reported. Virtually all of the fused cells were then inoculated into the selective medium. 
w  The concentrations of the selective drugs were 25 or 30 #g/ml BrdU and 50 vg/ml CAP. 
[[ The mean number of colonies observed in a number of flasks. 
￿82  Colonies  were counted  as soon  as they were clearly visible  to minimize the inclusion  of  satellite colonies in the 
COUntS. 
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Karyotypes and Morphology of Parents, Cybrids, and Hybrids from  the en296-1  ￿  BU25 System 
Number of chromosomes~t 
Cell line  Source*  ~  SD  N  excludedw  Morphologyll 
Parents 
296-1  HeLa $3 CAP  g  64.2  2.3  26  3.7 
BU25  HeLa $3 BrdU  g  59.3  1.7  29  9.4 
300-4b  296-1 TG g  65.2  3.4  30  0 
Cybrids 
HEB3A  en296-1  ￿  BU25  56.9  4.0  24  23 
HEB4A  en296-1  ￿  BU25  57.8  2.5  24  23 
HEB7A  en296-1  ￿  BU25  58.2  4.3  27  0 
Hybrids 
HAB2  300-4b ￿  BU25  118.6  8.2  30  0 
HAB3  300-4b ￿  BU25  119.6  8.5  30  0 
HAB4  300-4b ￿  BU25  118.5  10.0  30  0 
rounded 
flat 
fiat 
flat 
flat 
D 
m 
* The origin of the cell lines and the markers they contain, or the fusions from which the cybrids and hybrids were 
derived. Superscript R  indicates resistance to the drug named. 
:~ The mean chromosome number (X) for each parent or fusion product, the standard deviation (SD) from the mean, 
and the number of chromosome smears (N) sampled. 
w When the chromosome count  was extremely high,  close to  double the  mean,  or extremely low,  the count  was 
excluded from the sample as aberrant. The percentage of the total sample excluded on this basis is listed here. 
II See text. 
and the extreme difficulty experienced in obtaining 
CAP-resistant  colonies  originally  (39),  eliminate 
the  possibility  that  cybrid  formation  occurs  as  a 
result  of mutation  of the CAP-sensitive parent  to 
CAP  resistance. 
Other Systems ./'or Demonstrating 
Cytoplasmic Inheritance in Human  Cells 
By using 296-1  and the recloned cybrid HEB7A 
as donors, CAP  resistance has been transferred to 
420 
HEB7A 
I00,  -- 
296-! 
a:  60 
o 
BU25 
o  ioo 
CAP  /~g/mt 
FIG. 3  Effect of increasing concentration of CAP on the growth of the two parents, 296-1  and BU25, and 
the cybrid HEB7A. CAP sensitivity is measured as a percentage of the growth after 8 days of test cultures in 
CAP relative to control cultures in the absence of CAP.  Filled triangles (A) represent the CAP-resistant 
parent 296-1. Open circles (O) represent the CAP-sensitive parent BU25, and the filled circles (0) represent 
the cybrid. In the case of BU25, the approximately  10% of cells remaining at CAP concentrations of 50 
#g/ml  and  above  do  not  indicate  a  small  percentage of resistant  cells.  These  cells  are  shriveled and 
incapable of developing into colonies in the presence of CAP. However, they may remain attached to the 
substrate for some time. 
180  THE  JOURNAL OF CELL BIOLOGY .  VOLUME 67,  1975 two other human cell lines. The two recipient lines, 
S3AGI  and  WAL-2A,  are  HPRT  negative,  TG 
resistant, and CAP sensitive. TG was used in these 
experiments  because  AG  was  found  to  produce 
poor  selection  in  HeLa  cells.  TG,  on  the  other 
hand, is extremely toxic to HeLa cells, eliminating 
virtually  all  296-1  cells  exposed  to  10-'  M  in  7 
days. 
The  transfers  of  CAP  resistance  from  enu- 
cleated  HeLa  cells to  S3AG1  are  summarized  in 
TABLE  V 
Effect of Antibiotics on Mitochondrial Protein 
Synthesis In Vitro of  Parents 296-1 and BU25 and 
the Cybrid HEB7A 
Source of mitochondria* 
Treatment  296-1  BU25  HEB7A 
None  100:~  100  100 
+  100 #g/ml CAP  79  24  85 
+  200 #g/ml CHX  103  98  97 
* Mitochondria were purified from the various cell lines 
(see  Materials and  Methods) and  the  incorporation of 
[3H]leucine into protein was followed for 45 min at 30~ 
The  incorporation  of  [3H]leucine  in  the  absence  of 
antibiotics was 17,400 cpm/mg mitochondrial protein for 
296-1,  9,120  cpm/mg  protein  for  BU25,  and  19,800 
cpm/mg protein for HEB7A. 
:~ All values are expressed as a percentage of [3H]leucine 
incorporation in the absence of inhibitors. 
Table  VI.  In  the  first  experiment,  cells  of  the 
cybrid,  HEB7A,  were  enucleated  and  fused  to 
S3AG1  cells.  Each  parent  was  also  virus  treated 
and  all  preparations  were  diluted  and  inoculated 
into  flasks  of  MEM-E  containing  50  #g/ml  of 
CAP.  After  5  days,  the  medium  was  further 
supplemented with  10-' M  TG. 
A cytoplast from a cell containing HPRT should 
confer on a  cybrid not only its CAP resistance but 
also  temporary  TG  sensitivity,  HPRT  being  co- 
transferred. Thus, the addition of high levels of TG 
are delayd to permit the decay of the enzyme and 
the  re-expression  of the TG-resistant  genotype  in 
the cybrid. 
After only  13 days of incubation, colonies were 
clearly visible in every fusion flask while none were 
seen in either parental control. The colony number 
was  directly  related  to  the  number  of fused  cells 
plated.  The  overall  cybrid  frequency  was  1,200 
cybrids/10  e parental  cells.  This is eight times the 
frequency  seen  in  the  fusion  en296-1  ￿  BU25. 
Cultures  developing  from  this fusion  were  named 
BES. 
The  nuclear  characteristics  of  the  parents 
(HEB7A  and  S3AGI)  and  of  the  BES  cybrids 
(BES3,  BES5, and BES7) are shown in Table VII. 
The cybrids  BES3,  BES5,  and  BES7 each have a 
chromosome  number close  to that of S3AGI  and 
greater  than  that  of  HEB7A.  Also,  HEB7A  has 
inherited  the  flat  morphology  of  BU25,  while 
TABL~ VI 
Transfer of CA P Resistance to S3A G 1 and Demonstration of H PR T and CA P Resistance Cotransfer 
Enucle-  Total cells  Colonies/10  ~  Time  of  Culture 
Cells  ation*  fused:l:  Selective systemw  cells[I  count ￿82  designation 
%  da.vs 
enHEB7A x  S3AGI  57  107  CAP + delayed TG  1,200  13  BES 
enHEB7A  57  2 x  10  e  CAP + delayed TG  0  13  -- 
S3AGI  0  5 x  10  s  CAP + delayed TG  0  13  -- 
en296-1  x  S3AG1  55  107  CAP +  immediate TG  0.34  23  HES 
en296-1  55  5 x  106  CAP +  immediate TG  0  23  -- 
S3AGI  0  5 x  10  e  CAP +  immediate TG  0  23  -- 
296-1  ￿  S3AGI  0  10  ~  CAP +  immediate TG  0  23  -- 
* See Table III. 
~t See Table III. 
w In all cases CAP was used at 50 #g/ml and TG at 10 -~ M. At this level, TG has no effect on the growth of S3AGI 
but is extremely toxic to 296-1. Virtually all of the cells in a midlog phase culture of 296-1 are eliminated within 7 days. 
"Delayed TG" means that the TG was added  5 days after fusion to allow decay of HPRT carried with the CAP 
resistance in the cytoplasL "Immediate TG" means that the TG was added at the time of fusion. 
II The mean number of colonies averaged from a number of flasks,  in the en296-1  x  S3AGI  fusion, three colonies 
arose in separate flasks after inoculation of 8.8  x  106 fused cells. 
￿82  The days after fusion (day 0) at which colonies were counted. 
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 S3AGI  and the  three  BES  cybrids are  rounded. 
HEB7A is BrdU resistant and lacks most of its TK 
activity.  Since  cybrids  were  selected  with  TG, 
BrdU  resistance represents a nonselected marker. 
All of the BES cybrids are BrdU sensitive and have 
TK activity at least 10 times that of HEB7A, to be 
expected if their nuclei were derived from S3AG 1. 
The  BES  cybrids and  S3AGI  are  resistant to 
TG  but  HEB7A  is  not.  Examination of  HPRT 
activity  shows  that  HEB7A  exhibits  200  U  of 
activity; S3AG1  has none, like the  BES cybrids. 
The high rate of cybrid formation suggests that the 
colonies observed are not the results of mutation of 
HEB7A  to  TG  resistance.  All  of  these  results 
strongly  suggest  that  the  BES  cybrid nuclei are 
derived from S3AGI. 
The extremely high rate of cybrid formation in 
this experiment and the absence of any colonies in 
the  S3AGI  virus-treated  control  make  it  very 
unlikely that  such  results could  be  explained by 
mutation. This is further supported by the appear- 
ance of cybrid colonies in less than  13 days. 
To demonstrate that they cybrids were the result 
of the fusion of CAP-sensitive, TG-resistant cells 
with  CAP-resistant cytoplasts from  TG-sensitive 
cells,  advantage was taken of the fact that such  a 
transfer should impart a transient TG sensitivity to 
the cybrids. The extreme toxicity of 10 -~ M TG to 
sensitive HeLa cells suggested that cybrid forma- 
tion might be selected  against by addition of TG 
before  the  re-expression  of  the  HPRT-negative 
genotype.  A  reduction in the  number of cybrids 
would  demonstrate  that  the  selection  for  the 
CAP-resistant determinant also required the addi- 
tion  of  active  HPRT.  Since  the  sole  source  of 
HPRT in this experiment is the cytoplasm of the 
donor cell, this would show that the CAP resist- 
ance  was  carried  in  the  donor  cell's cytoplasm. 
HeLa 296-1 was chosen as the donor in this HPRT 
cotransfer experiment. 
HeLa 296-1  cells  were  enucleated and fused  to 
S3AGI; both parents were  also virus treated.  All 
three  preparations  were  inoculated directly  into 
flasks  containing medium  with  both  50  ~g/ml 
CAP and 10  -~ M TG (Table VI). Of the 8.8 ￿  106 
cells  inoculated,  only  three  clones  (designated 
HES) appeared  after 23 days, each  in a  separate 
flask.  No colonies appeared  in the parental con- 
trois. 
To determine if the  HES  clones could be the 
product  of a  fusion between two  nucleated cells 
followed  by  chromosome  loss,  nucleated  296-1 
cells were  fused to S3AGi  cells and the mixture 
was  inoculated directly into  10  -4  M  TG and  50 
#g/ml CAP.  All flasks were  negative at 26 days 
and  remained  so  despite  prolonged  incubation. 
This  result,  plus  the  negative parental controls, 
suggests that HES clones are cybrids. 
The enormous decrease in the number of cybrids 
caused by immediate rather than delayed addition 
of TG is proof that the CAP resistance is carried in 
the same structure which imparts the transient TG 
sensitivity. Thus, CAP resistance must be carried 
in the HeLa cytoplasts. 
The fact that three  HES cybrids did appear is 
evidence that fusion occurred. The appearance of 
these colonies could be explained if, in these cases, 
very small cytoplasts fused with the S3AGI cells. 
The  low  level  of  HPRT  added  by  the  small 
cytoplast  would  reduce  the  TG  toxicity.  The 
simultaneously low  input  of  the  CAP-resistant 
factor  would  require  a  longer  period  for  the 
selection  of  a  fully  resistant  cell.  This  could 
account for the increase from  13 to 26 days in the 
time  of cybrid  appearance.  The  isolation of the 
HES clones indicates that both HEB7A and 296-1 
can donate CAP resistance to S3AG I in a TG and 
CAP selection system. The use of cybrid HEB7A 
as  a  donor  proves  that  CAP  resistance  can  be 
transferred  sequentially  to  one  cell  line  after 
another. 
Four  different  procedures  have  been  used  to 
select for cybrid formation between enHEB7A and 
WAL-2A, the human lymphocyte line. In all cases, 
the  cells  were grown without agitation in RPMI 
1640 (see  Materials and Methods).  HEB7A cells 
have  been  found  to  attach  tenaciously  in  this 
medium, while the WAL-2A lymphocytes do not. 
Thus,  a  method  to  enrich  for  iymphocytes  is 
simply  to  swirl  the  Erlenmeyer  flask  or  bottle 
containing the  cells and then pour the  supernate 
into a new container ("pour-off" selection). 
Successful selection of CAP-resistant lympho- 
cyte  lines has  been  achieved  by  selection  in  50 
#g/ml CAP added  immediately, plus either  l0  -s 
M  or  l0  -* M TG added immediately after fusion 
as well as after a 5-day delay. However, it required 
67  days  for  the  culture  inoculated directly  into 
10-'  M  TG  to  grow.  Inoculation of  cells  into 
medium containing 10  -5 M TG or into medium to 
which  10 -s M TG or 10 -~ M TG was added after a 
5-day delay resulted in CAP-resistant lymphocytes 
in  25-26  days  (Table  VIII).  Virus-treated  en- 
HEB7A  or  WAL-2A under  identical conditions 
did not grow in any of the four experiments. The 
concerted  effect  of  pour-off  plus  TG  toxicity 
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 rapidly eliminated all enHEB7A. WAL-2A alone 
grew in CAP for about 1 wk at an ever-decreasing 
rate until all growth ceased. By 3 wk the cells were 
unable  to  exclude  the  vital  dye,  trypan  blue. 
Prolonged incubation of the WAL-2A cultures in 
50 ~g/ml CAP for 87 days with  10 -~  M  TG, 49 
days  with  10  -5  M  TG,  and  44  days  with  the 
delayed addition of TG resulted in no growth or 
viability. 
In the experiments involving the delayed addi- 
tion of TG, the fusion mixture was divided after 5 
days. Half of the culture received 10  -5 M TG and 
the other half 10 -~ M  TG. The combined results 
show  that  CAP-resistant lymphocytes have  been 
generated in three separate fusions and under four 
different selective  procedures. 
The  CAP-resistant  lines  resulting  from  these 
fusions have been designated HEW 2, 3, 4, and 5. 
The  cultures  have  now  been  grown  for  several 
months in 50 tag/ml CAP with and without TG. 
The HEW cybrids, although resistant to CAP, did 
not initially exhibit the same level of resistance as 
the  HEB7A  parent,  a  result  distinctly different 
from our observations of other human and mouse 
cybrids.  Prolonged culture, however,  produced  a 
fully resistant line which retains its CAP resistance 
for over 14 generations of growth in the absence of 
CAP. 
The  nuclear  characteristics  of  HEB7A  and 
WAL-2A  and  the  HEW  cybrids  are  shown  in 
Table VII. The chromosome number of HEB7A is 
58 which is substantially higher than the diploid 46 
seen in WAL-2A. The chromosome number for all 
the HEW cybrids is 46. HEB7A is an epithelial cell 
while WAL-2A and HEW 2, 3, 4, and 5 grow in 
suspension  as  lymphocytes.  WAL-2A  and  the 
HEW cybrids each show at least five times the TK 
activity of HEB7A and all are BrdU sensitive. No 
HPRT activity is  seen in WAL-2A or the  HEW 
lines, all of which  are TG resistant. 
Finally, invoking two  of the  criteria for  HeLa 
cell  identification  suggested  by  other  research 
groups (13,  31),  HEB7A  (being of HeLa  origin) 
should  contain G6PD,  variant A,  and  lack  a  Y 
chromosome.  WAL-2A  should  possess  G6PD, 
variant B, and have a Y chromosome. Both G6PD 
and the Y chromosome are nonselected markers in 
this system. Analysis of the parents and cybrids for 
G6PD isozymes and for the Y chromosome using 
Q  banding shows  that  HEB7A  is  indeed G6PD, 
variant  A,  and  lacks  a  Y  chromosome  while 
WAL-2A and the cybrids HEW 2, 3, 4, and 5 are 
all G6PD, variant B, and have a Y chromosome. 
From these data, it is concluded that HEW 2, 3, 4, 
and  5  contain  only  the  nuclear  information of 
WAL-2A.  However,  these  lines  are  now  CAP 
resistant  and  can  grow  indefinitely in  levels  of 
CAP to which the WAL-2A parent remains sensi- 
tive, even after virus treatment. 
It is clear that the cybrids isolated in all of the 
above fusions have the  nuclear characteristics of 
the  nucleated  parent.  All  cybrids  possess  these 
properties irrespective of the selective  system used 
or the cell types involved. 
DISCUSSION 
In these studies we have described a system for 
demonstrating cytoplasmic inheritance in human 
cells.  This has been accomplished by transferring 
CAP resistance from a resistant to a sensitive cell 
via  the  cytoplasm  and  in  the  absence  of  the 
nucleus. 
The  appearance  of the  cybrids cannot be  ex- 
plained  by  the  mutation  of  the  CAP-resistant 
parent  to  BrdU  or  TG  resistance.  Virus-treated 
CAP-resistant  cells  inoculated into  the  selective 
medium by themselves were consistently negative. 
Also, efforts to obtain cells resistant to BrdU (19), 
and  TG  (see  above)  require  mutagenesis  and 
several months of selection, whereas cybrid colo- 
nies  arise  in  a  few  weeks.  These  results  are 
confirmed by the evidence that the cybrid nucleus 
is derived from the CAP-sensitive parent. Cybrids 
were  observed to inherit the sensitive parent's (a) 
chromosome  number, (b)  gross  morphology,  (c) 
unselected genetic markers such as TK, (d) unique 
Y  chromosome,  (e)  G6PD  isozyme,  and  0')  se- 
lected markers,  such  as  HPRT deficiency. These 
lines  of  evidence  make  a  strong  case  against 
mutation of the CAP-resistant line to resistance to 
BrdU  or  TG.  They  are  entirely consistent with 
cybrid formation. 
Mammalian cells have been shown to contain a 
specific  mitochondrial thymidine kinase which  is 
retained even when the nuclear thymidine kinase is 
lost  (3,  8,  20).  Growing  a  BrdU-resistant  and 
CAP-sensitive cell in BrdU and CAP would result 
in the incorporation of the BrdU into the mtDNA. 
It is possible that this BrdU might act as a specific 
mutagen  rendering  the  cells  resistant  to  CAP. 
However,  the  lack  of  colony  formation  when 
virus-treated  CAP-sensitive  parental  cells  are 
plated  in  BrdU  and  CAP  and  the  successful 
formation of cybrids by selection in TG instead of 
WALLACE E'r AL.  Cytoplasmic Transfer of Chloramphenicol Resistance  185 BrdU  indicate  that  cybrid  formation cannot be 
explained  by  specific  BrdU  mutagenesis  of  the 
mtDNA. The high frequency of cybrid formation 
and the rapidity with which  colonies appear in all 
experiments are inconsistent with  mutation of the 
CAP-sensitive cells  to CAP resistance. To isolate 
CAP-resistant cells, ethidium bromide (EtBr) mu- 
tagenesis  and  several  months  of  selection  were 
required (39). 
Cybrid formation has been shown to require the 
fusion of a  CAP-resistant cytoplast with  a CAP- 
sensitive cell.  In the  fusion of an HPRT-positive 
and  CAP-resistant enucleated cell  to  an  HPRT- 
negative and CAP-sensitive nucleated cell,  it was 
shown that  CAP  resistance was  cotransferred  in 
the  same  structure  as  the  HPRT.  This  HPRT 
decayed over time. The only structure which could 
impart  unstable  HPRT  is  a  cytoplast  from  the 
CAP-resistant cell.  Thus, transfer of CAP resist- 
ance requires the fusion of a donor cytoplast. 
The  development  of  CAP  resistance  is  not 
simply the  result of a  change in the  ratio  of the 
volume of the cytoplasm relative to the nucleus of 
the  CAP-sensitive cell.  Fusion of cytoplasts and 
cells of different volumes was not found to affect 
cybrid formation. In the fusion en296-1  ￿  BU25, 
cells of smaller volume were enucleated and fused 
to larger cells. Conversely, in the fusion enHEB7A 
x  S3AGI, cells of larger volume were enucleated 
and  fused  to  smaller  cells.  The  nuclei  in  both 
fusions are very similar and CAP resistance was 
readily  transferred  in  both  experiments.  If  cell 
volume were the only factor in the development of 
CAP  resistance,  there  should  have  been  major 
differences in the success of these two experiments. 
Similarly, the  fusion  of  the  very  large  HEB7A 
cytoplasts to the very small WAL-2A cells should 
have  readily generated cybrids. On the contrary, 
this  was  the  more  difficult  fusion  to  perform. 
These data  argue against cybrid formation being 
the result of a simple change in the volume of the 
cytoplasm relative to the nucleus. 
The nature of the CAP resistance of the cybrids 
was examined in vivo by checking their tolerance 
to increasing levels of CAP.  It was  observed that 
cybrids were  resistant to the  same high  levels  of 
CAP as the CAP-resistant parent. Purified mito- 
chondria from one cybrid were found to synthesize 
protein in the presence of CAP at the same level as 
did  the  mitochondria  purified  from  the  CAP- 
resistant  parent.  The  same  CAP  concentration 
strongly inhibited mitochondrial protein synthesis 
in  the  sensitive  parent.  Thus,  cybrid  formation 
results in a cell as resistant to CAP as its resistant 
parent,  a  resistance which  occurs  at  the  level  of 
mitochondrial protein  synthesis.  The  transfer  of 
this mitochondrial resistance requires the fusion of 
the donor cytoplast. 
The appearance of cybrids cannot be explained 
by  nuclear-nuclear fusions  followed  by  segrega- 
tion of the chromosomes coding for TK or HPRT. 
A  fusion  using  the  same  selection  system  but 
involving nucleated CAP-resistant cells gave only 
1.5%  of  the  number of  colonies  observed  when 
enucleated cells were used.  Furthermore, selection 
for  nuclear-nuclear  fusions  utilizing  HAT  and 
CAP  produced  about  one-third the  colonies ob- 
served  in  cybrid  formation.  Such  hybrids  con- 
tained about twice the number of chromosomes as 
the cybrids. 
The  existence  of  forms  of  DNA  other  than 
mtDNA which are found in the cytoplasm make it 
impossible to  prove  by these  enucleation experi- 
ments  that  CAP  resistance  is  coded  in  the 
mtDNA.  Examples of these  types of DNA have 
been mentioned in a previous paper (7). Of the cell 
lines used in this study, DNA has been found in the 
cytoplasm of both  HeLa and WI-L2 cells.  HeLa 
has a cytoplasmic DNA of about 16S and a small 
polydisperse circular  DNA,  both  of which  origi- 
nate  in  the  nucleus  (23,  37). WI-L2  contains 
cmDNA synthesized in the nucleus which  can be 
picked up from the cytoplasm by vesicular stoma- 
titis virions (17,  29).  The nuclear origin of cyto- 
plasmic DNAs has been confirmed in a number of 
cultured cells (23). 
The fact that these DNAs require a nucleus for 
their synthesis decreases the probability that they 
could  transfer  CAP  resistance  via  cytoplasts. 
However, it is possible that the cytoplasmic DNA 
could  be  transferred  via  the  cytoplast,  migrate 
back to the sensitive nucleus, and recombine with 
the  CAP-sensitive gene.  Such  a  complex  model 
seems  unlikely in view  of the  high  frequency of 
transfers  observed.  Another  possibility  is  that 
there are plasmid-like genes that are both extranu- 
clear  and  extramitochondrial.  Such  genes  could 
transfer stable CAP  resistance.  Finally, the gene 
might  be  coded  in  the  mtDNA.  The  last  two 
possibilities cannot be distinguished by the current 
methods. However, experiments designed to trans- 
fer  CAP  resistance  using  isolated  mitochondria 
and purified mtDNA  are  under way  in order to 
clarify this point. 
186  THE  JOURNAL OF  CELL  BIOLOGY  ￿9 VOLUME  67,  1975 Resistance  to  CAP  is expressed  at  the  level of 
HeLa  mitochondrial  protein  synthesis  in  the  line 
296-1  (39).  The  mutant  was  isolated  after  treat- 
ment with the specific mtDNA  mutagen, ethidium 
bromide.  CAP  resistance  has  been  shown  to  be 
cytoplasmically  coded  in  Tetrahymena  (35)  and 
mitochondrially  coded  in  yeast  (9)  and  in 
Paramecium  (4).  It  therefore  seems  reasonable 
that  CAP  resistance  in  the  human  line  296-1  is 
coded  in the mtDNA. 
This study  represents the  first  genetic evidence 
of  cytoplasmic  inheritance  in  human  cells.  It 
describes a  genetic system for demonstrating cyto- 
plasmic inheritance in human cells and has shown 
that  CAP  resistance  can  be  transferred  sequen- 
tially from cell to cell and transferred to cells from 
widely different origins and differentiated states. 
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